Triveni Bio
PrivateLast Round
Series C
Jun 17, 2026
Est. Valuation
$390.53M
Total Funding Raised
$272M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Triveni Bio is a biotechnology company that develops a drug discovery platform focused on targeted therapies for inflammatory and immune disorders using a genetics-informed approach to enhance treatment precision and efficacy while minimizing toxicity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Triveni Bio Comps
Public and private peers based on sector, stage, and business model.
Triveni Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 17, 2026 | ||||
| Series B | Oct 2, 2024 | ||||
| Series A | Oct 26, 2023 |
Key People
Founding team and executive leadership
Triveni Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series C |
| Fidelity Management & Research Company | Series B |
| Deep Track Capital | Series C, Series B |
| OrbiMed | Series B, Series A |
| Cormorant Capital | Series A |
| Invus Opportunities | Series B, Series A |
| Viking Global Investors | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
$65M round led by Janus Henderson Group and Ascenta Capital
- Nov 1, 2025
Developing an IL-13 targeting asset for atopic dermatitis.
Triveni Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Triveni Bio's valuation, stock price, and market status.
